Top

Cancer Causes & Control

Published in:

01-05-2008 | Review Article

Predictors of colorectal cancer screening behaviors among average-risk older adults in the United States

Authors: Hind A. Beydoun, May A. Beydoun

Published in: Cancer Causes & Control | Issue 4/2008

Abstract

Objective

To critically evaluate recent studies that examined determinants of CRC screening behaviors among average-risk older adults (≥50 years) in the United States.

Methods

A PUBMED (1996–2006) search was conducted to identify recent articles that focused on predictors of CRC initiation and adherence to screening guidelines among average-risk older adults in the United States.

Results

Frequently reported predictors of CRC screening behaviors include older age, male gender, marriage, higher education, higher income, White race, non-Hispanic ethnicity, smoking history, presence of chronic diseases, family history of CRC, usual source of care, physician recommendation, utilization of other preventive health services, and health insurance coverage. Psychosocial predictors of CRC screening adherence are mostly constructs from the Health Belief Model, the most prominent of which are perceived barriers to CRC screening.

Conclusions

Evidence suggests that CRC screening is a complex behavior with multiple influences including personal characteristics, health insurance coverage, and physician–patient communication. Health promotion activities should target both patients and physicians, while focusing on increasing awareness of and accessibility to CRC screening tests among average-risk older adults in the United States.

Christman LK, Abdulla R, Jacobsen PB, Cantor AB, Mayhew DY, Thompson KS et al (2004) Colorectal cancer screening among a sample of community health center attendees. J Health Care Poor Underserved 15(2):281–293PubMedCrossRef

Clipp EC, Carver EH, Pollak KI, Puleo E, Emmons KM, Onken J, et al. (2004) Age-related vulnerabilities of older adults with colon adenomas: evidence from Project Prevent. Cancer 100(5):1085–1094PubMedCrossRef

Harewood GC, Wiersema MJ, Melton LJ III (2002) A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy. Am J Gastroenterol 97(12):3186–3194PubMedCrossRef

James AS, Campbell MK, Hudson MA (2002) Perceived barriers and benefits to colon cancer screening among African Americans in North Carolina: how does perception relate to screening behavior?. Cancer Epidemiol Biomarkers Prev 11(6):529–534PubMed

Matthews BA, Anderson RC, Nattinger AB (2005) Colorectal cancer screening behavior and health insurance status (United States). Cancer Causes Control 16(6):735–742PubMedCrossRef

Ahluwalia IB, Mack KA, Murphy W, Mokdad AH, Bales VS (2001) State-specific prevalence of selected chronic disease-related characteristics—Behavioral risk factor surveillance system

Tomeo CA, Colditz GA, Willett WC, Giovannucci E, Platz E, Rockhill B et al (1999) Harvard Report on Cancer Prevention. Volume 3: prevention of colon cancer in the United States. Cancer Causes Control 10(3):167–180PubMedCrossRef

Janz NK, Wren PA, Schottenfeld D, Guire KE (2003) Colorectal cancer screening attitudes and behavior: a population-based study. Prev Med 37(6 Pt 1):627–634PubMedCrossRef

Hawk ET, Levin B (2005) Colorectal cancer prevention. J Clin Oncol 23(2):378–391PubMedCrossRef

10.

Harvard Report on Cancer Prevention (1999) Prevention of colon cancer in the United States. Cancer Causes Control 10:167–180CrossRef

11.

Powe BD, Finnie R, Ko J (2006) Enhancing knowledge of colorectal cancer among African Americans: why are we waiting until age 50? Gastroenterol Nurs 29(1):42–49PubMedCrossRef

12.

Sheikh RA, Kapre S, Calof OM, Ward C, Raina A (2004) Screening preferences for colorectal cancer: a patient demographic study. South Med J 97(3):224–230PubMedCrossRef

13.

Huang CS, Lal SK, Farraye FA (2005) Colorectal cancer screening in average risk individuals. Cancer Causes Control 16(2):171–188PubMedCrossRef

14.

Levin TR, Palitz AM (2002) Flexible sigmoidoscopy: an important screening option for average-risk individuals. Gastrointestinal endoscopy clinics of North America 12(1):23–40, vi

15.

Maciosek MV, Solberg LI, Coffield AB, Edwards NM, Goodman MJ (2006) Colorectal cancer screening: health impact and cost effectiveness. Am J Prev Med 31(1):80–89PubMedCrossRef

16.

Cokkinides VE, Chao A, Smith RA, Vernon SW, Thun MJ (2003) Correlates of underutilization of colorectal cancer screening among U.S. adults, age 50 years and older. Prev Med 36(1):85–91PubMedCrossRef

17.

Bowie JV, Curbow BA, Garza MA, Dreyling EK, Benz Scott LA, McDonnell KA (2005) A review of breast, cervical, and colorectal cancer screening interventions in older women. Cancer Control 12(Suppl 2):58–69PubMed

18.

Pignone M, Levin B (2002) Recent developments in colorectal cancer screening and prevention. Am Fam Physician 66(2):297–302PubMed

19.

Plaza CI, Rane S (2003) Finance issue brief: mandated benefits: colorectal cancer screening coverage requirements: year end report-2003. Issue Brief Health Policy Track Serv 31:1–5

20.

Provenzale D, Gray RN (2004) Colorectal cancer screening and treatment: review of outcomes research. J Natl Cancer Inst Monogr (33):45–55

21.

Screening for colorectal cancer–United States, 1992–1993, and new guidelines (1996) MMWR 45(5):107–110

22.

Sonnenberg A, Delco F (2002) Cost-effectiveness of a single colonoscopy in screening for colorectal cancer. Arch Intern Med 162(2):163–168PubMedCrossRef

23.

Borum ML (2001) Colorectal cancer screening. Primary care. 28(3):661–674, viii

24.

Gazelle GS, McMahon PM, Scholz FJ (2000) Screening for colorectal cancer. Radiology 215(2):327–335PubMed

25.

Inadomi JM, Sonnenberg A (2000) The impact of colorectal cancer screening on life expectancy. Gastrointest Endosc 51(5):517–523PubMedCrossRef

26.

Mandel JS, Church TR, Ederer F, Bond JH (1999) Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 91(5):434–437PubMedCrossRef

27.

Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM (1992) Screening sigmoidoscopy and colorectal cancer mortality. Journal of the J Natl Cancer Inst 84(20):1572–1575PubMedCrossRef

28.

Rudy DR, Zdon MJ (2000) Update on colorectal cancer. Am Fam Physician 61(6):1759–1770, 73–74

29.

Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS (1992) A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. New Engl J Med 326(10):653–657PubMedCrossRef

30.

Souza RF (2001) A molecular rationale for the how, when and why of colorectal cancer screening. Aliment Pharmacol Therap 15(4):451–462CrossRef

31.

Theuer CP, Wagner JL, Taylor TH, Brewster WR, Tran D, McLaren CE, et al. (2001) Racial and ethnic colorectal cancer patterns affect the cost-effectiveness of colorectal cancer screening in the United States. Gastroenterology 120(4):848–856PubMedCrossRef

32.

Vernon SW (1997) Participation in colorectal cancer screening: a review. J Natl Cancer Inst 89(19):1406–1422PubMedCrossRef

33.

Vijan S, Hwang EW, Hofer TP, Hayward RA (2001) Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. Am J Med 111(8):593–601PubMedCrossRef

34.

Winawer SJ, Stewart ET, Zauber AG, Bond JH, Ansel H, Waye JD et al (2000) A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. New Engl J Med 342(24):1766–1772PubMedCrossRef

35.

Winawer SJ, Zauber AG, Ho MN, O’Brien MJ, Gottlieb LS, Sternberg SS et al (1993) Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. New Engl J Med 329(27):1977–1981PubMedCrossRef

36.

Etzioni DA, Yano EM, Rubenstein LV, Lee ML, Ko CY, Brook RH et al (2006) Measuring the quality of colorectal cancer screening: the importance of follow-up. Dis Colon Rectum 49(7):1002–1010PubMedCrossRef

37.

Ko CW, Sonnenberg A (2005) Comparing risks and benefits of colorectal cancer screening in elderly patients. Gastroenterology 129(4):1163–1170PubMedCrossRef

38.

Lai SM, Zhang KB, Uhler RJ, Harrison JN, Clutter GG, Williams MA (2006) Geographic variation in the incidence of colorectal cancer in the United States, 1998–2001. Cancer 107(5 Suppl):1172–1180PubMedCrossRef

39.

From the Centers for Disease Control and Prevention (2001) Trends in screening for colorectal cancer–United States, 1997 and 1999. Jama 285(12):1570–1571

40.

Increased use of colorectal cancer tests–United States, 2002 and 2004 (2006) MMWR 55(11):308–311

41.

Claes E, Denayer L, Evers-Kiebooms G, Boogaerts A, Philippe K, Tejpar S et al (2005) Predictive testing for hereditary nonpolyposis colorectal cancer: subjective perception regarding colorectal and endometrial cancer, distress, and health-related behavior at one year post-test. Genet Test 9(1):54–65PubMedCrossRef

42.

Clavel-Chapelon F, Joseph R, Goulard H (1999) Surveillance behavior of women with a reported family history of colorectal cancer. Prev Med 28(2):174–178PubMedCrossRef

43.

Collins V, Meiser B, Gaff C, St John DJ, Halliday J (2005) Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma. Cancer 104(2):273–281PubMedCrossRef

44.

Manne S, Markowitz A, Winawer S, Guillem J, Meropol NJ, Haller D et al. (2003) Understanding intention to undergo colonoscopy among intermediate-risk siblings of colorectal cancer patients: a test of a mediational model. Prev Med 36(1):71–84PubMedCrossRef

45.

Manne S, Markowitz A, Winawer S, Meropol NJ, Haller D, Rakowski W et al (2002) Correlates of colorectal cancer screening compliance and stage of adoption among siblings of individuals with early onset colorectal cancer. Health Psychol 21(1):3–15PubMedCrossRef

46.

Ko CW, Kreuter W, Baldwin LM (2002) Effect of Medicare coverage on use of invasive colorectal cancer screening tests. Arch Intern Med 162(22):2581–2586PubMedCrossRef

47.

Colorectal cancer test use among persons aged > or =50 years–United States, 2001 (2003) MMWR 52(10):193–196

48.

Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R (2001) Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst 93(22):1704–1713PubMedCrossRef

49.

Ahluwalia IB, Mack KA, Murphy W, Mokdad AH, Bales VS (2003) State-specific prevalence of selected chronic disease-related characteristics–Behavioral Risk Factor Surveillance System, 2001. MMWR Surveill Summ 52(8):1–80PubMed

50.

Nelson DE, Bolen J, Marcus S, Wells HE, Meissner H (2003) Cancer screening estimates for U.S. metropolitan areas. Am J Prev Med 24(4):301–309PubMedCrossRef

51.

Trends in screening for colorectal cancer–United States, 1997 and 1999. (2001) MMWR 50(9):162–166

52.

Coughlin SS, Thompson TD (2004) Colorectal cancer screening practices among men and women in rural and nonrural areas of the United States, 1999. J Rural Health Spring 20(2):118–124CrossRef

53.

Goodman MJ, Ogdie A, Kanamori MJ, Canar J, O’Malley AS (2006) Barriers and facilitators of colorectal cancer screening among Mid-Atlantic Latinos: focus group findings. Ethnic Dis 16(1):255–261

54.

Honda K, Gorin SS (2005) Modeling pathways to affective barriers on colorectal cancer screening among Japanese Americans. J Behav Med 28(2):115–124PubMedCrossRef

55.

James TM, Greiner KA, Ellerbeck EF, Feng C, Ahluwalia JS (2006) Disparities in colorectal cancer screening: a guideline-based analysis of adherence. Ethnic Dis 16(1):228–233

56.

Rustgi AK (2004) Breaking the barriers to colorectal cancer screening. Gastroenterology 126(5):1232–1233

57.

Marcus AC, Mason M, Wolfe P, Rimer BK, Lipkus I, Strecher V et al (2005) The efficacy of tailored print materials in promoting colorectal cancer screening: results from a randomized trial involving callers to the National Cancer Institute’s Cancer Information Service. J Health Commun 10(Suppl 1):83–104PubMedCrossRef

58.

Ferreira MR, Dolan NC, Fitzgibbon ML, Davis TC, Gorby N, Ladewski L et al (2005) Health care provider-directed intervention to increase colorectal cancer screening among veterans: results of a randomized controlled trial. J Clin Oncol 23(7):1548–1554PubMedCrossRef

59.

Gilbert A, Kanarek N (2005) Colorectal cancer screening: physician recommendation is influential advice to Marylanders. Prev Med 41(2):367–379PubMedCrossRef

60.

Tessaro I, Mangone C, Parkar I, Pawar V (2006) Knowledge, barriers, and predictors of colorectal cancer screening in an Appalachian church population. Prev Chronic Dis 3(4):A123PubMed

61.

Rao RS, Graubard BI, Breen N, Gastwirth JL (2004) Understanding the factors underlying disparities in cancer screening rates using the Peters-Belson approach: results from the 1998 National Health Interview Survey. Med Care 42(8):789–800PubMedCrossRef

62.

Codori AM, Petersen GM, Miglioretti DL, Boyd P (2001) Health beliefs and endoscopic screening for colorectal cancer: potential for cancer prevention. Prev Med 33(2 Pt 1):128–136PubMed

63.

Lieberman D (2005) Race, gender, and colorectal cancer screening. Am J Gastroenterol 100(12):2756–2758PubMedCrossRef

64.

Busch S (2003) Elderly African American women’s knowledge and belief about colorectal cancer. Abnf J 14(5):99–103PubMed

65.

Ioannou GN, Chapko MK, Dominitz JA (2003) Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol 98(9):2082–2091PubMedCrossRef

66.

Fisher DA, Dougherty K, Martin C, Galanko J, Provenzale D, Sandler RS (2004) Race and colorectal cancer screening: a population-based study in North Carolina. North Carolina Med J 65(1):12–15

67.

Honda K (2004) Factors associated with colorectal cancer screening among the US urban Japanese population. Am J Publ Health 94(5):815–822

68.

Sun WY, Basch CE, Wolf RL, Li XJ (2004) Factors associated with colorectal cancer screening among Chinese-Americans. Prev Med 39(2):323–329PubMedCrossRef

69.

Walsh JM, Kaplan CP, Nguyen B, Gildengorin G, McPhee SJ, Perez-Stable EJ (2004) Barriers to colorectal cancer screening in Latino and Vietnamese Americans. Compared with non-Latino white Americans. J Gen Intern Med 19(2):156–166PubMedCrossRef

70.

Honda K, Kagawa-Singer M (2006) Cognitive mediators linking social support networks to colorectal cancer screening adherence. J Behav Med 29(5):449–460PubMedCrossRef

71.

Janz NK, Lakhani I, Vijan S, Hawley ST, Chung LK, Katz SJ (2007) Determinants of colorectal cancer screening use, attempts, and non-use. Prev Med 44:452–458PubMedCrossRef

72.

Klabunde CN, Schenck AP, Davis WW (2006) Barriers to colorectal cancer screening among Medicare consumers. Am J Prev Med 30(4):313–319PubMedCrossRef

73.

Carlos RC, Underwood W III, Fendrick AM, Bernstein SJ (2005) Behavioral associations between prostate and colon cancer screening. J Am Coll Surg 200(2):216–223PubMedCrossRef

74.

Meissner HI, Breen N, Klabunde CN, Vernon SW (2006) Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev 15(2):389–394PubMedCrossRef

75.

Pollack LA, Blackman DK, Wilson KM, Seeff LC, Nadel MR (2006) Colorectal cancer test use among Hispanic and non-Hispanic U.S. populations. Prev Chronic Dis 3(2):A50PubMed

76.

Sirovich BE, Schwartz LM, Woloshin S (2003) Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? Jama 289(11):1414–1420PubMedCrossRef

77.

Carlos RC, Fendrick AM, Abrahamse PH, Dong Q, Patterson SK, Bernstein SJ (2005) Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors. Women Health Issue 15(6):249–257CrossRef

78.

Molina L, Carlos RC, Mark Fendrick A, Abrahamse PH, Dong Q, Bernstein SJ (2004) Completion of colorectal cancer screening in women attending screening mammography. Acad Radiol 11(11):1237–1241PubMedCrossRef

79.

Lemon S, Zapka J, Puleo E, Luckmann R, Chasan-Taber L (2001) Colorectal cancer screening participation: comparisons with mammography and prostate-specific antigen screening. Am J Publ Health 91(8):1264–1272

80.

Tang TS, Solomon LJ, McCracken LM (2001) Barriers to fecal occult blood testing and sigmoidoscopy among older Chinese-American women. Cancer Pract 9(6):277–282PubMedCrossRef

81.

Yip MP, Tu SP, Chun A, Yasui Y, Taylor VM (2006) Participation in colorectal cancer screening among Chinese Americans. Asian Pac J Cancer Prev 7(4):645–650PubMed

82.

Hay JL, Ford JS, Klein D, Primavera LH, Buckley TR, Stein TR et al (2003) Adherence to colorectal cancer screening in mammography-adherent older women. J Behav Med 26(6):553–576PubMedCrossRef

83.

Lafata JE, Divine G, Moon C, Williams LK (2006) Patient–physician colorectal cancer screening discussions and screening use. Am J Prev Med 31(3):202–209PubMedCrossRef

84.

Shah M, Zhu K, Potter J (2006) Hispanic acculturation and utilization of colorectal cancer screening in the United States. Cancer Detect Prev 30(3):306–312PubMedCrossRef

85.

Thompson B, Coronado G, Neuhouser M, Chen L (2005) Colorectal carcinoma screening among Hispanics and non-Hispanic whites in a rural setting. Cancer 103(12):2491–2498PubMedCrossRef

86.

Brouse CH, Basch CE, Wolf RL, Shmukler C (2004) Barriers to colorectal cancer screening: an educational diagnosis. J Cancer Educ 19(3):170–173PubMedCrossRef

87.

Farraye FA, Wong M, Hurwitz S, Puleo E, Emmons K, Wallace MB et al (2004) Barriers to endoscopic colorectal cancer screening: are women different from men? Am J Gastroenterol 99(2):341–349PubMedCrossRef

88.

Dulai GS, Farmer MM, Ganz PA, Bernaards CA, Qi K, Dietrich AJ, et al. (2004) Primary care provider perceptions of barriers to and facilitators of colorectal cancer screening in a managed care setting. Cancer 100(9):1843–1852PubMedCrossRef

89.

Klabunde CN, Vernon SW, Nadel MR, Breen N, Seeff LC, Brown ML (2005) Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults. Med Care 43(9):939–944PubMedCrossRef

90.

Brouse CH, Basch CE, Wolf RL, Shmukler C, Neugut AI, Shea S (2003) Barriers to colorectal cancer screening with fecal occult blood testing in a predominantly minority urban population: a qualitative study. Am J Publ Health 93(8):1268–1271CrossRef

91.

Farraye FA, Horton K, Hersey H, Trnka Y, Heeren T, Provenzale D (2004) Screening flexible sigmoidoscopy using an upper endoscope is better tolerated by women. Am J Gastroenterol 99(6):1074–1080PubMedCrossRef

92.

Janz NK, Champion VL, Strecher VJ (2002) The health belief model. In: Glanz K, Rimer BK, Lewis FM (eds) Health behavior and health education, 3rd edn. John Wiley & Sons Inc, San Francisco

93.

Prochaska JO, DiClemente CC (1983) Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol 51(3):390–395PubMedCrossRef

94.

Prochaska JO, Redding CA, Evers K (2002) The Transtheoretical model and stages of change. In: Glanz K, Rimer BK, Lewis FM (eds) Health behavior and health education—theory, research and practice. 3rd edn. John Wiley & Sons Inc, San Francisco

95.

Myers RE, Ross E, Jepson C, Wolf T, Balshem A, Millner L et al (1994) Modeling adherence to colorectal cancer screening. Prev Med 23(2):142–151PubMedCrossRef

Title: Predictors of colorectal cancer screening behaviors among average-risk older adults in the United States
Authors: Hind A. Beydoun
May A. Beydoun
Publication date: 01-05-2008
Publisher: Springer Netherlands
Published in: Cancer Causes & Control / Issue 4/2008
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-007-9100-y

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 4/2008

Prognostic factors in women with breast cancer: inequalities by ethnicity and socioeconomic position in New Zealand

Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997–2002

Cigarette smoking and risk of epithelial ovarian cancer

Exposure to traffic emissions throughout life and risk of breast cancer

The changing patterns of bladder cancer in Egypt over the past 26 years

Brian MacMahon (1923–2007): founder of modern epidemiology

Keynote webinar | Spotlight on antibody–drug conjugates in cancer